TCTMD: Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA

Older adults represent the fastest-growing population of patients in the United States, and stable ischemic heart disease is extremely common in this group.

Older patients enrolled in the ISCHEMIA trial saw their angina symptoms improve with an invasive strategy as compared with more conservative management, but unlike younger patients in the trial, they did not report the same improvements in overall health status, according to a new analysis.

As with the overall trial, older patients did not have any improvement in hard clinical outcomes with an invasive approach, Dan Nguyen, MD, a medical post graduate with Saint Luke's Mid America Heart Institute, and colleagues report in the Journal of the American College of Cardiology.

Read the full TCTMD article: Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA

Related Content

Aug. 22, 2022

TCTMD: Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

Medication nonadherence was common and associated with worse health status among the patients with stable coronary disease in the ISCHEMIA trial, r

stethoscope laying on of of data sheets with computer and physician hands on keyboard with research and data points
Mar. 30, 2020

NIH-funded studies show stents and surgery no better than medication, lifestyle changes at reducing cardiac events
Saint Luke's Director of Health Outcomes and Research at Saint Luke's Mid America Heart Institute helps in NIH-funded studies that find stents, surgery provide higher quality of life for those with chest pain.
Dr. John Spertus, director of health outcomes research at Saint Luke's Mid America Heart Institute
Dec. 27, 2019

Kansas City Business Journal: 5 questions with Saint Luke's cardiologist that co-led groundbreaking new study
Dr. John Spertus talks to the Kansas City Business Journal about his new groundbreaking ISCHEMIA study and how precision medicine will change the business of cardiology.